Article

Targeting the CALCB/RAMP1-axis inhibits growth of Ewing sarcoma

medRxiv · 2018 · Dallmayer, M.; Li, J.; Ohmura, S.; Alba-Rubio, R.; Baldauf, M. C.; Hoelting, T. L. B.; Musa, J.; Knott, M. M. L.; Stein, S.; Cidre-Aranaz, F.; Wehweck, F. S.; Romero-Perez, L.; Gerke, J. S.; Orth, M. F.; Marchetto, A.; Kirchner, T.; Bach, H.; Sannino, G.; Grunewald, T. G. P.

Key facts

Title Targeting the CALCB/RAMP1-axis inhibits growth of Ewing sarcoma
First author Dallmayer, M.; Li, J.; Ohmura, S.; Alba-Rubio, R.; Baldauf, M. C.; Hoelting, T. L. B.; Musa, J.; Knott, M. M. L.; Stein, S.; Cidre-Aranaz, F.; Wehweck, F. S.; Romero-Perez, L.; Gerke, J. S.; Orth, M. F.; Marchetto, A.; Kirchner, T.; Bach, H.; Sannino, G.; Grunewald, T. G. P.
Journal medRxiv
Published Dec 8, 2018
DOI 10.1101/491100
Devices mentioned K810863
Product codes mentioned DBM, NJT, NSU, PFX

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature